Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP2 Beyond the Dewormer: Benzimidazoles' Groundbreaking Impact on Global Health
Fenben® Voices
6 minutes
2 years ago
S1EP2 Beyond the Dewormer: Benzimidazoles' Groundbreaking Impact on Global Health
Got Questions? Send us a message!Episode Description:Dive deep with us in "Beyond the Dewormer: Benzimidazoles' Groundbreaking Impact on Global Health," where we uncover the transformative journey of benzimidazole anthelmintics from veterinary staples to WHO-endorsed essential medicines for human health. This episode explores:The Anthelmintic Legacy: Understanding benzimidazoles and their pivotal role in treating parasitic infections.WHO’s Stamp of Approval: Insights into the recognition of M...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
